More on AUTL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.0 Score)
- Holders

Upcoming Events

- Earnings (10/29/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Autolus Therapeutics (NQ:AUTL)
Delayed: 1.60 -0.12 (6.98%)
Prev. Close $1.72  
Open$1.74 
52 Wk High$ 
52 Wk Low$ 
Day High$1.74 
Day Low$1.59 
P/E N/A  
EPS$ 
Volume2,349,803 

Friends, Peers and Foes (?): A, AVBP, IPH, IPHA, 0A3M (more...)

Oct 5, 2026 08:30 AM Autolus Therapeutics to Present Longer-Term Follow Up Data from CARLYSLE Trial at the American College of Rheumatology Convergence 2026
Sep 23, 2026 06:04 AM Form EFFECT Autolus Therapeutics
Sep 22, 2026 04:51 PM Form 424B3 Autolus Therapeutics
Sep 15, 2026 04:22 PM Form DEL AM Autolus Therapeutics
Sep 14, 2026 06:02 AM Form S-3 Autolus Therapeutics
Sep 9, 2026 07:01 AM FDA grants RMAT designation to Autolus drug for lupus treatment
Sep 9, 2026 07:00 AM Autolus Therapeutics Announces FDA RMAT Designation Granted to Obe-cel for the Treatment of Systemic Lupus Erythematosus and Lupus Nephritis
Aug 28, 2026 09:08 PM Form SCHEDULE 13D/A Autolus Therapeutics Filed by: PPF Group a.s.
Aug 14, 2026 10:02 AM Form SCHEDULE 13G/A Autolus Therapeutics Filed by: ARMISTICE CAPITAL, LLC
Aug 11, 2026 04:15 PM Form 10-Q Autolus Therapeutics For: Jun 30
View All Articles

Entities mentioned with AUTL

View All Entities